Innovative biomarkers for neurodegenerative disease diagnosis.

Our cutting-edge kits are designed to address the diagnostic needs in the field of neurodegenerative diseases. Below, you’ll find information about our latest offerings.


Customized and unique tests enhancing neurodegenerative disease diagnosis and aiding neurologists and healthcare professionals in taking informed patient management decisions.


MemoryLinc® serves as a tracking tool for Alzheimer’s Disease progression. By monitoring specific markers, physicians can assess the pathology’s evolution in patients affected by this debilitating condition.


NeuroLINCs is a panel of blood-based biomarkers specifically designed for early detection of neurological disorders. Its unparalleled accuracy aids in diagnosing conditions such as Parkinson’s Disease and multiple sclerosis.


NeuroDeGene® offers a comprehensive screening test for neurodegenerative diseases. By combining multiple biomarkers, it provides a holistic assessment of brain health.


APO-Easy® is a genotyping kit that assesses the genetic risk associated with Alzheimer’s Disease. With just a small blood sample, this test analyzes the APOE gene genotype, providing insights for both patients and healthcare professionals.

Get in touch